Accuro's integration of artificial intelligence with ultrasound (AI-US) provides detailed ultrasound image-analysis pivotal in complex clinical scenarios. CHARLOTTESVILLE, VA, August 16, 2022 — RIVANNA®, developers of world-first, imaging-based medical solutions,...
Medical Technology Leader to Advise Commercialization Strategy for Next-Generation Products CHARLOTTESVILLE, VA, July 7, 2022 — RIVANNA®, developers of world-first, imaging-based medical solutions, has named Nikki Troiano Gainey, a MedTech corporate and...
Experienced Manufacturing Leader Integrates LEAN Principles to Maximize Quality and Productivity CHARLOTTESVILLE, VA, July 13, 2022 — RIVANNA®, developers of world-first, imaging-based medical solutions, has appointed Mikel Lewis, an experienced life science...
CHARLOTTESVILLE, VA, DECEMBER 1, 2021 — RIVANNA®, developers of world-first, imaging-based medical solutions, announced they have entered into a partnership with BOMImed, a recognized manufacturer of anesthesia and critical care related consumables to represent and...
CHARLOTTESVILLE, Virginia — RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the purchase of a 10,000 square-foot facility in Charlottesville, Virginia, with acreage earmarked for new construction. The venture accommodates...
Danielle Faulk answers some of the most frequently asked questions about Accuro. Accuro has maximum storage capacities of 10,000 images, 300 videos, and 999 exams....
Q: First, what is Accuro, exactly? A: Accuro® is an easy-to-learn, AI-enabled epidural guidance device such that anesthesia providers with—even minimal ultrasound experience—can take advantage of its powerful image recognition technology. Accuro significantly...
CHARLOTTESVILLE, VA, SEPTEMBER 13, 2021 — RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the results of a recent randomized controlled trial (RCT) showing that Accuro® automated spinal navigation system significantly enhanced...
CHARLOTTESVILLE, VA, September 8, 2021 — RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the results of a prospective, double-blind study demonstrating that the Accuro® Epidural Guidance device with SpineNav3D™...
Accuro guidance helps eliminate challenges associated with epidural placement for high BMI patients. By Dr. Regina Fragneto It’s no secret that childbirth hurts. For most women, it is characterized by intense pain and pressure in the lower abdomen and back...
CHARLOTTESVILLE, VA, August 4, 2021 — RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the first semester of the Teach-Accuro CRNA Educators Project. The new initiative provides the Accuro® spinal navigation system at no cost to...
CHARLOTTESVILLE, VA, July 13, 2021 — RIVANNA®, developers of world-first, imaging-based medical solutions, today announced sales of the Accuro device and related service and equipment increased 263% versus the same period of the prior year following second-quarter...
CHARLOTTESVILLE, VA, JUNE 2, 2021—RIVANNA®, developers of world-first, imaging-based medical solutions, announced the European Patent Office has issued RIVANNA a notice of allowance for European patent application No. 13803513.4 entitled “Ultrasound Imaging of...
CHARLOTTESVILLE, VA, MAY 4, 2021—RIVANNA®, developers of world-first, imaging-based medical solutions, announced they have entered into a partnership with Tri-anim Health Services, a specialty distributor of respiratory, anesthesia, and critical-care supplies, to...
UK's NICE Publishes Medtech Innovation Briefing on Accuro for Guiding Epidural or Spinal Anaesthesia to Reduce Needle Insertions Compared with Palpation Alone in People with Obesity CHARLOTTESVILLE, VA., April 13, 2021—RIVANNA®, developers of world-first,...
RIVANNA Launches Accuro Second Generation With BoneEnhance® Multi-Frequency Image Reconstruction And SpineNav3D™ AI-Based Spine Recognition CHARLOTTESVILLE, VA., March 23, 2021 — RIVANNA®, developers of world-first, imaging-based medical solutions, announces...
Real-time needle guidance for paramedian epidural and spinal anesthesia maximizes image guidance efficiency CHARLOTTESVILLE, VA., November 16, 2020 – RIVANNA® today announced launch of its second-generation Accuro® automated spinal navigation system, combining...
"As an anesthesiologist performing epidurals and spinals, we're one of the few specialties not using imaging technology regularly to find the epidural space; this is an advancement that is due in our specialty." —Stephen Garber MDAnesthesiologist, Medical Director...
A Quick 101: Neuraxial ultrasound is primarily based on imaging of spinal bone structures; improved depth of field is of paramount importance with the resolution being of lesser concern. Bone is a specular reflector meaning the ultrasound wave reflects similarly to...
Accuro’s automated image interpretation. Notice the blue overlay on the Accuro display image; this indicates the spinous process cross-section is detected. When scanning a particular intervertebral level, if no orange interlaminar-space overlay appears, the...
Growing Patent Portfolio Paves the Way for Product Line Expansion CHARLOTTESVILLE, VA., June 26, 2020 — RIVANNA® today announced three new patents for its Accuro® ultrasound-based spinal navigation system, bringing the company's portfolio covering its core...
Palpation alone to determine the appropriate needle trajectory is recognized as a contributing factor in the acquisition of non-diagnostic BMTB specimens [1, 2]. CHARLOTTESVILLE, VA, May 20, 2020 — RIVANNA announced that the company was awarded a $1.5M...
Hand-held Ultrasound Device Accurate for Neuraxial Depth and Landmark Assessment
Increasingly Practice Guidelines Recommend Image Guidance for Spinal Needle Placement Procedures CHARLOTTESVILLE, VA., February 19, 2020 — RIVANNA® today announced that sales of its Accuro ultrasound-based spinal navigation system more than doubled in 2019 compared...
Latest Clinical Trial Results Highlight the Benefits of RIVANNA® Accuro® for Spinal Anesthesia in Patients Undergoing Orthopedic Surgery Automated Spinal Navigation Device Reduced Needle Redirects by 48% for Experienced Anesthesia Providers CHARLOTTESVILLE, VA.,...
Governor Northam Announces Life Science, Cancer Research Advancing in Virginia with $3.3 Million ‘Catalyst’ Awards: RIVANNA receives an $800,000 grant to develop Accuro 3S
OB/GYN ultrasound: is the field ready to adopt new technology in the market?
RCT of 150 spinal anesthesia procedures demonstrates Accuro’s improved success rates, patient satisfaction, and needle insertion time versus blind needle guidance
An Accuro Success Story: Rapid Placement Of Neuraxial Block In Morbidly Obese Parturient To Avoid General Anesthesia. Beth Ann Clayton, DNP, MS, CRNA — Associate Professor of Clinical Nursing, University of Cincinnati BACKGROUND Neuraxial...
Automated ultrasound guidance streamlines epidural placement for challenging patients in labor
Ultrasound guidance improves neuraxial anesthesia safety
Rivanna tackles epidural failure rates with its hand-held imaging device
Wireless, handheld spinal ultrasound takes the guesswork out of epidural needle placement
Local company develops ultrasound technology to facilitate anesthesia delivery
NIH: Pocket-sized imaging device improves accuracy of epidural placement
Hand-held Ultrasound Device Accurate for Neuraxial Depth and Landmark Assessment
SOAP Clinical Research Presentations Prove the Benefits of RIVANNA Spinal Navigation System
Rivanna Medical Receives Health Canada Approval for Accuro™ Spinal Navigation System
Accuro™ used in world’s first image-guided epidural in patient with rare neurological condition
RIVANNA Announces Multiple Key Patents for Accuro™ and Accuro Locator™
RIVANNA Secures $3.5 Million in Growth Financing
RIVANNA Awarded $1.5M NIH Grant for Rapid Ultrasound-based 3D Bone Fracture Assessment in the Emergency Department
RIVANNA Announces Partnership with UK-based Vertec Scientific
RIVANNA prepares for European Market adoption of Accuro™ with the appointment of a new Vice President of Sales, Europe, the Middle East, and Africa (EMEA)
RIVANNA Launches International Expansion in the Middle East with Easy-to-use, Automated Ultrasound
Accuro™ highlighted in “AORA 2015” scientific presentation by Anand M. Sardesai, MD, Anesthesiologist, Cambridge (UK) University Hospital: “Advances in Ultrasound Machine Technology and Future Trends”
RIVANNA commences manufacturing of its Accuro™ device for launch at annual meeting of the American Society of Anesthesiologists (ASA)
RIVANNA appoints Rebecca D. Minehart, M.D., Assistant Professor of Anesthesia, Massachusetts General Hospital, as a clinical advisor
RIVANNA appoints Brendan Carvalho, M.D., Stanford Univ. Medical Center, as a clinical advisor
RIVANNA has received FDA clearance for Accuro™
Article features the RIVANNA UVA alumni